MIRAGEN THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of Debt SecuritiesIndenture • March 31st, 2017 • Miragen Therapeutics, Inc. • Services-medical laboratories • New York
Contract Type FiledMarch 31st, 2017 Company Industry JurisdictionINDENTURE, dated as of , among MIRAGEN THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
MIRAGEN THERAPEUTICS, INC. and , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OFCommon Stock Warrant Agreement • March 31st, 2017 • Miragen Therapeutics, Inc. • Services-medical laboratories • New York
Contract Type FiledMarch 31st, 2017 Company Industry JurisdictionThis COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between MIRAGEN THERAPEUTICS, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).